hotspot -WSS

hotspot

author：comprehensive 2025-10-01 02:13:52 - browse：1

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： The new shift in health care is toward less care

entertainment

focus

WSS

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Change Healthcare payments predicted restored March 15

In his State of the Union, Biden takes clear aim at 'Big Pharma'

The new shift in health care is toward less care

Former medical device CEO who sold dummy, plastic parts convicted of fraud

focus

hotspot

entertainment

Virginia high school admissions case could be legal follow

Excited delirium, Elijah McClain, and emergency physicians

Alkermes shareholders re

NEJM study link tiny plastics in blood vessels to heart problems

At least 13 dead in Texas as scorching temps continue

Sanofi CEO defends move to abandon profit guidance, boost research

ChatGPT in medicine: STAT answers readers' burning questions

Free speech concerns arise in wake of journal editor Eisen's firing

What does generative AI mean for health care? We asked experts

10 million people disenrolled from Medicaid over past six months

hotspot

Ambulance rides for just $100? Advisers want major billing fixes

Novo Nordisk obesity pill bests Wegovy in early trial

The drug industry has found itself all alone in Washington

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Removing probiotics from the NICU could threaten preemies' health

Free speech concerns arise in wake of journal editor Eisen's firing

entertainment

focus

hotspot

leisure time